Meet CTI
Corporate Strategy
Milestones
Technologies
Our People & Subsidiaries
Collaborations & Partnerships
FAQ
Community Involvement
Development
Pixantrone
OPAXIO
™
Brostallicin
Novel Bisplatinum Analogues
Medical Inquiries for Healthcare Professionals
Medical Inquiries for Patients & Caregivers
Clinical Trials
Patient Resources
Lung Cancer Clinical Trials
Ovarian Cancer Clinical Trials
Other Clinical Trials
Investors
Press Room
News
Press Kits
Media Library
Media Contacts
Careers
Compensation & Benefits
Living in Seattle
Job Opportunities
Italiano
Site Map
News
Stock
SEC Filings
Events & Webcasts
Annual Meeting
Investor Updates
Annual Reports
Financial Details
Corporate Governance
Investor FAQ
Information Request
Email Alerts
Print this page
Email this page
Guestbook
Registration
Please complete the following form. All information is kept confidential and is for internal use only. Thank you and enjoy the presentation.
Salutation
Mr.
Mrs.
Ms.
Dr.
First Name
*
Last Name
*
E-mail
*
Company
* Indicates Required Field
Submitting this form indicates your acceptance of the
Privacy Statement
.
CTI Fact Sheet (201K PDF)
Most Viewed Links
1.
Current News Release
2.
SEC Filings
3.
Comunicati stampa
4.
Cell Therapeutics, Inc. (CTI) Advances Pixantrone Filing Process in Europe; Submits Expanded Pediatric Investigation Plan (PIP)
5.
Press Room